1Benavides J,Schoemaker H,Dana C. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent[J].{H}Arzneimittel-Forschung,1995,(05):551-558.
2赵辨.临床皮肤病学[M]{H}南京:江苏科学技术出版社,2001613-618.
3Tworek D,Bocheńska-Marciniak M,Kupczyk M. The effect of weeks treatment with desloratadine (5mg daily) on levels of interleukin(IL)-4,IL-10,IL-18 and TGF beta in patients suffering from seasonal allergic rhinitis[J].{H}PULMONARY PHARMACOLOGY & THERAPEUTICS,2007,(03):244-249.
4Bachert C,van Cauwenberge P. Desloratadine for intermittent and persistent allergic rhinitis:a review[J].{H}Clinical Therapeutice,2007,(09):1795-1802.
5Reinartz SM,Overbeek SE,Klejnjan A. Desloratadin treatment reduces systemic allergic inflammation following nasal allergen provocation in patients with allergic rhinitis and astma[J].{H}ALLERGY,2005,(10):1301-1307.
